Apollo Hospitals Enterprise Limited vs Bafna Pharmaceuticals Limited
A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Bafna Pharmaceuticals Limited (BAFNAPH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs BAFNAPH on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability40
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
APOLLOHOSP takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
- − ["Stock is trading at 11.97 times its book value"]
- + ["Company has delivered good sales growth of 16.2% CAGR over last 5 years"]
- − ["Stock is trading at 11.35 times its book value", "Company has a low return on equity of 8.7% over last 3 years.", "Though the company is reporting repeated profits, it is not paying out dividend"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.